Lee Capital Holdings’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,000
Closed -$788K 9
2022
Q4
$788K Hold
10,000
1.2% 24
2022
Q3
$703K Hold
10,000
0.99% 25
2022
Q2
$801K Hold
10,000
0.63% 44
2022
Q1
$758K Hold
10,000
0.42% 48
2021
Q4
$853K Hold
10,000
0.45% 51
2021
Q3
$756K Hold
10,000
0.4% 54
2021
Q2
$814K Hold
10,000
0.41% 54
2021
Q1
$788K Hold
10,000
0.35% 71
2020
Q4
$855K Hold
10,000
0.5% 56
2020
Q3
$772K Hold
10,000
0.45% 48
2020
Q2
$733K Buy
10,000
+2,000
+25% +$142K 0.67% 38
2020
Q1
$531K Hold
8,000
0.44% 49
2019
Q4
$551K Hold
8,000
0.51% 46
2019
Q3
$588K Hold
8,000
0.55% 44
2019
Q2
$573K Hold
8,000
0.61% 43
2019
Q1
$548K Hold
8,000
0.61% 45
2018
Q4
$476K Hold
8,000
0.71% 35
2018
Q3
$536K Hold
8,000
0.38% 68
2018
Q2
$518K Buy
+8,000
New +$523K 0.37% 66

Other funds holding CL

Lee Capital Holdings's CL Position: Q1 2023 in Review

Lee Capital Holdings sold out of Colgate-Palmolive (CL) in Q1 2023, closing a stake of 10,000 shares — an estimated $788K sold.

Lee Capital Holdings first reported a position in CL in Q2 2018 and held it in 19 quarters. The position peaked at $855K in Q4 2020. 1,658 funds tracked by Wall St. Rank hold CL as of Q1 2023.

  • Lee Capital Holdings reported no remaining Colgate-Palmolive position as of Q1 2023 after selling out during the quarter.
  • Lee Capital Holdings sold 10,000 Colgate-Palmolive shares in Q1 2023, an estimated $788K.
  • Lee Capital Holdings first reported a position in Colgate-Palmolive in Q2 2018 and held it in 19 quarters.
  • Lee Capital Holdings's Colgate-Palmolive position peaked at $855K in Q4 2020.
  • 1,658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2023.

Based on Lee Capital Holdings's 13F filing for Q1 2023.